4.5 Article

Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice

Related references

Note: Only part of the references are listed.
Article Dermatology

The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis

Yujie Dong et al.

Summary: Combination treatment with tacrolimus and phototherapy was more effective than phototherapy alone for patients with vitiligo, especially in lesions located in the face and proximal limbs. Children had a higher excellent response rate, and other demographic and clinical variables such as gender and disease duration did not significantly impact treatment effectiveness. Further large-scale, well-executed trials are needed to confirm these findings.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)

Review Immunology

Vitiligo: Mechanisms of Pathogenesis and Treatment

Michael L. Frisoli et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Letter Dermatology

Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo

P. Mobasher et al.

BRITISH JOURNAL OF DERMATOLOGY (2020)

Article Dermatology

Phototherapy for Vitiligo

Raheel Zubair et al.

DERMATOLOGIC CLINICS (2020)

Article Chemistry, Medicinal

Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization

Stanca A. Birlea et al.

MEDICINAL RESEARCH REVIEWS (2017)

Article Dermatology

The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo

Tasneem F. Mohammad et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Dermatology

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Lucy Y. Liu et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Dermatology

New discoveries in the pathogenesis and classification of vitiligo

Michelle Rodrigues et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Review Dermatology

JAK inhibitors in dermatology: The promise of a new drug class

William Damsky et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Dermatology

Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo

Boon-Kee Goh et al.

DERMATOLOGIC CLINICS (2017)

Article Dermatology

Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo

Juan Jesus Sosa et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Article Medicine, General & Internal

Vitiligo

Khaled Ezzedine et al.

LANCET (2015)

Article Dermatology

Tofacitinib Citrate for the Treatment of Vitiligo A Pathogenesis-Directed Therapy

Brittany G. Craiglow et al.

JAMA DERMATOLOGY (2015)

Article Dermatology

T helper 17 and Tregs: a novel proposedmechanism for NB-UVB in vitiligo

Rehab A. Hegazy et al.

EXPERIMENTAL DERMATOLOGY (2014)

Article Dermatology

A comparative study of the mini-punch grafting and hair follicle transplantation in the treatment of refractory and stable vitiligo

Mohammad Ali Mapar et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)

Article Dermatology

Acral vitiligo and lesions over joints treated with non-cultured epidermal cell suspension transplantation

A. P. Holla et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)

Article Dermatology

Guidelines for the diagnosis and treatment of vitiligo in Japan

Naoki Oiso et al.

JOURNAL OF DERMATOLOGY (2013)

Article Dermatology

Acral lesions of vitiligo: why are they resistant to photochemotherapy?

S. M. Esmat et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)

Review Dermatology

Guideline for the diagnosis and management of vitiligo

D. J. Gawkrodger et al.

BRITISH JOURNAL OF DERMATOLOGY (2008)

Article Dermatology

Efficacy, predictors of response, and long-term follow-up in patients with vitiligo, treated with narrowband UVB phototherapy

Electra Nicolaidou et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)

Review Immunology

Mechanisms of type-I- and type-II-interferon-mediated signalling

LC Platanias

NATURE REVIEWS IMMUNOLOGY (2005)